Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Phase IV Data Meets Primary Endpoint PHILADELPHIA, PA, September 25, 2010 – Today Astellas Pharma US, Inc., (“Astellas”) announced results of a Phase IV study showing Lexiscan®...
PHILADELPHIA, PA, September 24, 2010 - Today Astellas Pharma US, Inc. ("Astellas") announced the Launch of the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging application (app) for...
Read more about New Smartphone App Launches For Cardiac Imaging Test
DEERFIELD, IL, September 15, 2010 – Astellas Pharma US, Inc. has announced the winners of the second 2010 Transplant Scholars Awards, which awarded a dozen $5,000 educational scholarships to...
SANTA MONICA, Calif.- Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate...
Astellas Launches Science WoRx Program Aimed to Ignite Students' Passion for Science and Cultivate the Next Generation of Scientists Today Astellas Pharma US, Inc. ("Astellas") announced the...
Company Breaks Ground in Glenview, Will Create 150 Jobs GLENVIEW, IL – April 29, 2010. Governor Pat Quinn today announced an approximately $4 million investment package to assist Astellas Pharma...
Read more about Governor Quinn Announces Astellas Pharma U.S. Chooses Illinois for New Headquarters
MELVILLE, N.Y., Apr 29, 2010 (BUSINESS WIRE) -- OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that its international partner for Tarceva® (erlotinib), Roche, received approval from the...
MELVILLE, N.Y., Apr 26, 2010 (BUSINESS WIRE) -- OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that it has completed enrollment in the RADIANT study, a Phase III clinical trial testing...
First Maintenance Therapy Approved For a Broad Patient Population Including Squamous and Non- Squamous Histology MELVILLE, N.Y., Apr 16, 2010 (BUSINESS WIRE) -- OSI Pharmaceuticals, Inc. (NASDAQ:...
Survey Reveals Pervasive Donation Myths RICHMOND, Va. (April 5, 2010) – According to a new survey by Donate Life America, 43 percent of people are undecided, reluctant or do not wish to have...
MELVILLE, N.Y., Mar 19, 2010 (BUSINESS WIRE) -- OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that its international partner for Tarceva(R) (erlotinib), Roche, informed OSI that the...
MELVILLE, N.Y. & SOUTH SAN FRANCISCO, Calif., Jan 15, 2010 (BUSINESS WIRE) -- OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG;...
Innovative Needle-Free Delivery System Provides Fast Migraine Relief SAN DIEGO, Calif. and DEERFIELD, Ill., January 13, 2010 — Zogenix, Inc. (“Zogenix”), a privately held pharmaceutical...
Fourth Quarter U.S. Tarceva Sales Increased 17% on Prior Year to $137 Million Total Global Tarceva Sales for 2009 Top $1.2 Billion MELVILLE, N.Y., Jan 12, 2010 (BUSINESS WIRE) -- OSI...
MELVILLE, N.Y., Dec 29, 2009 (BUSINESS WIRE) -- OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065,...
GAITHERSBURG, Md., Dec 16, 2009 (BUSINESS WIRE) -- OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG)(OTCQX: RHHBY), announced...
MOTTEP Honors Astellas for Commitment to Transplant Community Deerfield, IL (December 7, 2009) – Astellas Pharma US, Inc. was inducted into the National Minority Organ Tissue Transplant...
Read more about Astellas Inducted into National Minority Transplant Hall of Fame
MELVILLE, N.Y., Nov 16, 2009 (BUSINESS WIRE) -- OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that the Oncologic Drugs Advisory Committee (ODAC) will review the use of Tarceva(R)...
SOUTH SAN FRANCISCO, CA and DEERFIELD, IL – November 5, 2009 – Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today the commercial launch of VIBATIV™ (telavancin) in...
Vancouver, Canada and Deerfield, Illinois, USA, October 28, 2009 -- Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) and its co-development partner Astellas Pharma US, Inc. (“Astellas”)...
Read more about Cardiome and Astellas Announce Initiation of Patient Enrollment in Act 5 Trial
Challenge to state of Illinois: 5,000 new organ donor registrations by the end of the year Deerfield, IL (October 26, 2009) – On November 1, 1999 Chicago Bears fans and the organ donation...
Data Published in Headache Highlights Bioequivalence, Safety and Ease of Use SAN DIEGO, CA and Deerfield, IL - (October 22, 2009): Zogenix, Inc. (“Zogenix”), a privately held pharmaceutical...
Study finds aminophylline needs comparable to current standard Minneapolis – October 2, 2009 – A new analysis reaffirms that Lexiscan® (regadenoson) Injection, the first selective A2A...
DEERFIELD, IL, September 22, 2009 – Astellas Pharma US, Inc. has announced the winners of the first annual Astellas Transplant Scholars Awards, $5,000 educational scholarships awarded to six...
Astellas provides ongoing support for greater Chicago-area science teachers to advance their career skills DEERFIELD, IL, September 21, 2009 – Astellas Pharma US, Inc. (“Astellas”), in...
Follow U.S. news
